Ads
related to: sava stock optionslp.stockstotrade.com has been visited by 10K+ users in the past month
webull.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
As I discussed in my last article on Cassava Sciences (NASDAQ:SAVA), controversy continues to weigh on the performance of SAVA stock. Over the past week, shares in the clinical-stage biotech firm ...
Sometimes, it’s hard to know who or what to believe. Such is the case when it comes to the ongoing U.S. Securities and Exchange Commission (SEC) probe into Cassava Sciences (NASDAQ:SAVA). As the ...
Cassava Sciences (NASDAQ:SAVA) announced on July 21 that it would present two new clinical datasets in the upcoming Denver Alzheimer’s conference. The most important of these two will be on July ...
Cassava Sciences (NASDAQ:SAVA) stock took off once again during September. Rumors about the Securities and Exchange Commission (or SEC) clearing its investigation of the scandal-tarnished biotech ...
Cassava Sciences (NASDAQ:SAVA) stands to gain a good deal this year. This will all depend on the company’s Phase 3 clinical trials progress in the results on actual patients with Alzheimer’s ...
Early in October, I said that Cassava Sciences’ (NASDAQ:SAVA) big gains in late September had investors dreaming of a big payday for SAVA stock in 2022. Source: Pavel Kapysh / Shutterstock.com I ...